Celgene Corporation and Norvatis Pharmaceuticals Sues Actavis South Atlantic
April 19, 2011
Celgene Corporation and Norvatis Pharmaceuticals files suit against Actavis South Atlantic over six patents related to ADHD medicine. 4/15, District of New Jersey, 2:2011cv02162.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
